It provokes a high production of pro-inflammatory cytokines such as interleukin (IL)-1β and IL-18 in response to the danger signals in tumour microenvironment (TME), resulting in the activation of a pro-inflammatory immune response [23,24,25]. This evidence concerns the gene IL18 and neoplasm.